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(Reprinted from Nature, Vol. 211, No. 5056, p. 1422 only, 
September 24, 1966) 
Skin Tumours and Sarcomata induced in Rats 
by N- Hydroxy-2-acetylaminofluorene 
IT has been recently found that when 2-acetylamino-
fluorene (AAF) and several other carcinogenic amines 
are administered to rats, N -hydroxylation of the com-
pound occurs in ViV0 1 ,2. Using AAF, or several other 
amines, it has been shown that the N-hydroxy metabolite 
(N-OH-AAF) was a more active carcinogen than the 
parent compound 3 • 
It was therefore proposed that N-OH-AAF may be 
the proximate carcinogen when AAF is administered to 
rats4 • In the course of some preliminary experiments we 
have obtained additional evidence for this proposition. 
Ten 8-week-old male MRC rats (210 g), were injected 
once subcutaneously on the back with 5 mg of N-OH-
AAF dissolved in 0·5 ml. of warm olive oil. A week later 
a shaved area lof interscapular skin was painted with a 
2 per cent sohi,tion of N-OH-AAF in acetone, using a 
fine hair brush. \ The rats were painted at first three times, 
and later five times a week until the fortieth week, when 
they had been treated 125 times. The animals were given 
powdered laboratory chow and as much water as they 
wanted to drink. Once a week they were weighed and 
carefully inspected. At the twentieth week signs of skin 
irritation and exudation appeared, and by the thirty-
third week ulcers were present on most of the animals. 
At the thirty-fifth week a crop of skin tumours suddenly 
arose, and their progress was recorded weekly on graph 
paper maps. One rat died of pneumonia at 25 weeks 
without any other lesions, and the remaining nine rats 
were killed when their tumours caused a decline in health. 
A total of ten subcutaneous tumours occurred near the 
site of the initial injection in seven of the nine surviving 
rats. Eight of these were invasive fibrosarcomata, and 
two were well differentiated, relatively benign, fibrous 
tumours. Most of the subcutaneous tumours were a little 
distant from the original "site of injection, no doubt as a 
result of migration of the oily solution. The latent period 
for the subcutaneous tumours varied from 20 to 44 weeks, 
with a mean latency of 29·6 weeks. 
The earliest skin tumour in the painted area was found 
in the twenty-first week, and by the thirty-seventh week 
all the surviving rats had tumours in the painted areas. 
Six out of nine rats survived longer than 35 weeks, and 
had a total of sixty skin tumou.rs. The number of skin 
tumours on each rat increased steadily from the twenty-
fifth to the fifty -second week, when the final animal was 
killed. Only four of the original sixty tumours regressed. 
Of the fifty -six tumours which persisted, twenty (36 per 
cent) showed a steady increase in size, and "\vere found on 
histological examination to be invasive carcinomata. The 
majority of the carcinomata were of the squamous type, 
but a few were basal-cell carcinomata. The morphology 
of the benign tumours was similar to that described for 
mouse skin tumours 5 • Six rats had eight primary tumours 
which arose at a distance from the painted areas, namely in 
the Zymbal glands, breast, and lungs. One of the Zymbal 
tumours and one of the breast tumours metastasized 
widely. 
The induction of malignant skin tumours in rats by 
painting with N-OH-AAF was striking in view of the 
usual refractoriness of rat skin to chemical carcinogens. 
In rats painted with the parent compounds 2-AAF and 
2-AF, skin tumours are very rare, and nearly always occur 
at a distance from the painted area. The present results, 
therefore, provide strong evidence for the local action of 
N-OH-AAF as a direct carcinogen for rat skin and sub-
cutaneous tissue, without metabolic modification. It is 
considered that the single subcutaneous injection at the 
beginning of the experiment could not have much in-
fluenced the r~sponse of the skin. The experiments are 
being' repeatea and skin tumours have alreflrly been 
obtained by p~inting alone. The occurrence of sarcomata 
at or near the site of injection is also of interest in that they 
appear to have been caused by a single injection, whereas 
in work reported previously, multiple injections were 
given6 • The fact that combined treatment was given com-
plicates this interpretation, however, because the occur-
rence of distant neoplasms indicates that there must have 
been significant absorption either ofN-OH-AAF or of its 
parent amines. Furthermore, it is impossible, at present, 
to state what influence the painting may have had in the 
appearance of the subcutaneous tumours. 
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